OTC · CIK 0001644963
ATXI AVENUE THERAPEUTICS, INC.
Insider trading from SEC Form 4. Last filing Jan 6, 2026. Close $0.43 on Oct 9, 2026, +187% from the 52-week low and -54% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
3
with a Form 4 at this company
Price and insider trades, last year
ATXIOct 9, 2026 · close 0.43
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at AVENUE THERAPEUTICS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | Neil Herskowitz director sell | $46 23 shares | -19% | - | |
| 15Weak | Jay D Kranzler director sell | $137 61 shares | -10% | - |
Transactions
The last 4 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +111,209 | $0.00 | $0 | 439,733 | Jan 6, 2026 |
| Mar 31, 2025 | Fortress Biotech, Inc. owner | AGrant or award COMMON STOCK, PAR VALUE $0.0001 | +33,724 | $0.00 | $0 | 328,524 | Apr 2, 2025 |
| Dec 2, 2024 | Neil Herskowitz director | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -23 | $2.00 | $46 | 97 | Dec 3, 2024 |
| Nov 5, 2024 | Jay D Kranzler director | SOpen-market sale COMMON STOCK, PAR VALUE $0.0001 | -61 | $2.24 | $137 | 559 | Nov 7, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Fortress Biotech, Inc.owner
- Neil Herskowitzdirector
- Jay D Kranzlerdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.